Skip to main content

Synergus

  • Home
  • About
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Projects for good
    • Contact Us
    • Subscribe to Synergus RWE News
  • Real World Evidence
    • Real World Data Sources
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Diagnostics
    • Digital Health
      • European Review and Strategy
      • Evidence Requirements and Outcomes
      • Evidence Strategy and Development
      • Reimbursement Application and Hands-On Support
      • Digital Health Germany
    • Medical Device
      • Market access strategy
        • Market Access Overview
      • Hands-on market access support
      • Reimbursement dossier / HTA dossier
      • Reimbursement/DRG analysis
    • Countries
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog

  • Home
  • About
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Projects for good
    • Subscribe to Synergus RWE News
    • Contact Us
  • Real World Evidence
    • Real World Data Sources
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Diagnostics
    • Digital Health
      • European Review and Strategy
      • Evidence Requirements and Outcomes
      • Evidence Strategy and Development
      • Reimbursement Application and Hands-On Support
      • Digital Health Germany
    • Medical Device
      • Market access strategy
        • Market Access Overview
      • Reimbursement/DRG analysis
      • Reimbursement dossier / HTA dossier
      • Hands-on market access support
    • Countries
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog

Blog

High-quality RWE – Transparency about data quality
10 Aug 2022

Tags:
Real World EvidenceSweden
read more
Reimbursement may not be the primary barrier for digital health!?
04 Mar 2022

Tags:
Digital HealthGermany
read more
The German NUB process, the most risky process for a start-up?
08 Feb 2022

Tags:
GermanyCoverage with Evidence DevelopmentInnovation Funding
read more
The best real-world data setting for diabetes research – How much data is required?
21 Jan 2022

The Swedish setting provides an extremely rich data set with very high quality for diabetes research.

Tags:
DiabetesReal World EvidenceReal World Data
read more
Five digital solutions approved for temporary reimbursement in Germany – Up to 2000 €/year in reimbursement
09 Nov 2020

Tags:
Digital HealthGermany
read more
Do we know what the problem is that we are trying to solve regarding the COVID-19 Pandemic?
27 Mar 2020

Tags:
COVID-19
read more
Close to 400 diagnostic and digital health solutions to fight COVID-19, how we do select the right one?
26 Mar 2020

Tags:
COVID-19
read more
Solutions to fight the COVID-19 pandemic
20 Mar 2020

Tags:
Corona virus
read more
What is the status of diagnostic and digital health solutions to fight the corona pandemic?
19 Mar 2020

Tags:
Corona virus
read more
Status update: Digital Health Frameworks in Europe
10 Mar 2020

We are continuing 

Tags:
HTA
read more
  • Show More

Contact us

Tags

Alzheimer
Alzheimer Payer Readiness
Artificial Intelligence
China
Co-payment
Corona virus
Country specific
Coverage with Evidence Development
COVID-19
Data Science in Oncology
Dementia
Denmark
Diabetes
Digital Health
Digital Heath Strategies
Disease Specific
EMA
Empowered Patients
EQ-5D
Finland
France
Funding
Germany
Health Economics
Heart Failure
HTA
Imaging
Innovation Funding
Italy
IVD
Legislation
Lung Cancer
Market Access
Medical Device
Melanoma
Mental Health
Netherlands
Norway
Obesity
Oncology
Out-patient procedures
Patient Registries
Quality of Life
Real World Data
Real World Evidence
RefugeeMD
Registries
Rheumatoid Arthritis
RWE Sources
SF-36
Stroke
Sweden
The Netherlands
Throat Cancer
Transferability of Outcomes
United Kingdom
Value Based Healthcare
  • Home
  • About
  • Real World Evidence
  • Market Access
  • HEOR
  • Events/Webinars
  • News
  • Blog